Srs Capital Advisors, Inc. Neogenomics Inc Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 59 shares of NEO stock, worth $814. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59Holding current value
$814% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$272 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$195 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$121 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$92.9 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$91.4 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.74B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...